Kevin M. Lalande insider trades

Open-market stock purchases and sales by Kevin M. Lalande, Director at Lumos Pharma, Inc, from SEC Form 4 filings since Oct 8, 2013.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • (LUMO) Lumos Pharma, Inc: 19 buys, last Dec 12, 2024
  • MTEM Molecular Templates, Inc: 3 buys, 2 sales, last Sep 27, 2024
  • LDRH LDR Holding Corp: 3 sales, last Jul 13, 2016

Get free alerts when Kevin M. Lalande files a new trade →